I Andresen Selected Research

Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)

1/2003

Efficacy, tolerability, safety and pharmacokinetics of a nanofiltered intravenous immunoglobulin: studies in patients with immune thrombocytopenic purpura and primary immunodeficiencies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

I Andresen Research Topics

Disease

3	Hereditary Angioedemas 01/2019 - 04/2017
2	Angioedema 06/2017 - 04/2017
1	Hereditary Angioedema Types I and II 12/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2017
1	Peptic Esophagitis (Reflux Esophagitis) 06/2017
1	Gastritis 06/2017
1	Acquired angioedema 04/2017
1	Purpura 04/2008
1	Primary Immunodeficiency Diseases 04/2008
1	Relapsing-Remitting Multiple Sclerosis 11/2007
1	Chronic Progressive Multiple Sclerosis 11/2007
1	Body Weight (Weight, Body) 01/2003
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2003
1	Headache (Headaches) 07/2000

Drug/Important Bio-Agent (IBA)

5	icatibantIBA 12/2021 - 04/2017
4	Intravenous Immunoglobulins (IVIG)FDA Link 04/2008 - 07/2000
1	Bradykinin B2 ReceptorIBA 01/2019
1	BradykininIBA 07/2017
1	Pharmaceutical PreparationsIBA 06/2017
1	Inosine Triphosphate (ITP)IBA 01/2003